Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Isaacs

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Gastroenterology|August 2, 2003
Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trialWilliam J Sandborn, Daniel H Present, Kim L Isaacs, et al.
Inflammatory Bowel Diseases|October 9, 2018
Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter CohortKimberly N Weaver, Martin Gregory, Gaurav Syal, et al.
Crohn'S & Colitis 360|November 1, 2019
Chronic Antibiotic Dependent Pouchitis Is Associated With Older Age at the Time of Ileal Pouch Anal Anastomosis (J-pouch) SurgeryKimberly N Weaver, Bharati Kochar, Jonathan J Hansen, et al.
Inflammatory Bowel Diseases|March 21, 2013
Ciprofloxacin for the prevention of postoperative recurrence in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot studyHans H Herfarth, Jeffry A Katz, Stephen B Hanauer, et al.
The Journal of Investigative Dermatology|August 28, 2009
Diminished neural and cognitive responses to facial expressions of disgust in patients with psoriasis: a functional magnetic resonance imaging studyC Elise Kleyn, Shane McKie, Andrew R Ross, et al.
Inflammatory Bowel Diseases|September 7, 2016
Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and AnswersHans H Herfarth, Susan Jackson, Barbara G Schliebe, et al.
Alimentary Pharmacology & Therapeutics|June 6, 2003
Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trialW J Sandborn, B E Sands, D C Wolf, et al.
The American Journal of Gastroenterology|October 15, 2009
NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African AmericansThemistocles Dassopoulos, Geoffrey C Nguyen, Monica Vladut Talor, et al.
Inflammatory Bowel Diseases|July 13, 2015
MicroRNAs Classify Different Disease Behavior Phenotypes of Crohn's Disease and May Have Prognostic UtilityBailey C E Peck, Matthew Weiser, Saangyoung E Lee, et al.
Gastroenterology|August 28, 1999
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study GroupW J Sandborn, W J Tremaine, D C Wolf, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Gastroenterology|August 2, 2003
Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trialWilliam J Sandborn, Daniel H Present, Kim L Isaacs, et al.
Inflammatory Bowel Diseases|October 9, 2018
Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter CohortKimberly N Weaver, Martin Gregory, Gaurav Syal, et al.
Crohn'S & Colitis 360|November 1, 2019
Chronic Antibiotic Dependent Pouchitis Is Associated With Older Age at the Time of Ileal Pouch Anal Anastomosis (J-pouch) SurgeryKimberly N Weaver, Bharati Kochar, Jonathan J Hansen, et al.
Inflammatory Bowel Diseases|March 21, 2013
Ciprofloxacin for the prevention of postoperative recurrence in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot studyHans H Herfarth, Jeffry A Katz, Stephen B Hanauer, et al.
The Journal of Investigative Dermatology|August 28, 2009
Diminished neural and cognitive responses to facial expressions of disgust in patients with psoriasis: a functional magnetic resonance imaging studyC Elise Kleyn, Shane McKie, Andrew R Ross, et al.
Inflammatory Bowel Diseases|September 7, 2016
Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and AnswersHans H Herfarth, Susan Jackson, Barbara G Schliebe, et al.
Alimentary Pharmacology & Therapeutics|June 6, 2003
Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trialW J Sandborn, B E Sands, D C Wolf, et al.
The American Journal of Gastroenterology|October 15, 2009
NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African AmericansThemistocles Dassopoulos, Geoffrey C Nguyen, Monica Vladut Talor, et al.
Inflammatory Bowel Diseases|July 13, 2015
MicroRNAs Classify Different Disease Behavior Phenotypes of Crohn's Disease and May Have Prognostic UtilityBailey C E Peck, Matthew Weiser, Saangyoung E Lee, et al.
Gastroenterology|August 28, 1999
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study GroupW J Sandborn, W J Tremaine, D C Wolf, et al.
Pageof 11